The Journal of Immunological Methods is devoted to covering techniques for:(1) Quantitating and detecting antibodies and/or antigens. (2) Purifying immunoglobulins, lymphokines and other molecules of the immune system. (3) Isolating antigens and other substances important in immunological processes. (4) Labelling antigens and antibodies. (5) Localizing antigens and/or antibodies in tissues and cells. (6) Detecting, and fractionating immunocompetent cells. (7) Assaying for cellular immunity. (8) Documenting cell-cell interactions. (9) Initiating immunity and unresponsiveness. (10) Transplanting tissues. (11) Studying items closely related to immunity such as complement, reticuloendothelial system and others. (12) Molecular techniques for studying immune cells and their receptors. (13) Imaging of the immune system. (14) Methods for production or their fragments in eukaryotic and prokaryotic cells. (15) Computational methods including statistical and mathematical methods and computational models for analysis, visualization, and interpretation of results.Submitted full length manuscripts should describe new methods of broad applicability to immunology and not simply the application of an established method - although papers describing such applications may be considered for publication as a short Technical Note. Review articles will also be published by the Journal of Immunological Methods, but these manuscripts are by invitation only.
Official Journal of the Japanese Society of Legal Medicine.Legal Medicine provides an international forum for the publication of original articles, reviews and correspondence on subjects that cover practical and theoretical areas of interest relating to the wide range of legal medicine.Subjects covered include forensic pathology, toxicology, odontology, anthropology, criminalistics, immunochemistry, hemogenetics and forensic aspects of biological science with emphasis on DNA analysis and molecular biology. Submissions dealing with medicolegal problems such as malpractice, insurance, child abuse or ethics in medical practice are also acceptable.
Affiliated with the American Society for Matrix Biology and the International Society for Matrix BiologyMatrix Biology is the leading journal devoted to publishing the latest research on molecular components of the extracellular matrix and the biological impact of cellular interactions with extracellular matrices. We welcome articles in any area of extracellular matrix research that provide new mechanistic and functional insights, have significant potential impact for the field, or which challenge longstanding biological paradigms. Matrix Biology publishes original studies in, but not limited to, cell and molecular biology, developmental biology, genetics, structural biology, chronobiology, infection and immunity, immunology, virology, signaling, disease mechanisms, and therapeutics related to the extracellular matrix and its interactions with cells. Papers considered for peer review must document substantial advances for the field of extracellular matrix and/or cell-matrix interactions. In addition to original research articles, Matrix Biology welcomes highly timely, impactful reviews. Please view our Guide for Authors for more information. Reasons to submit your next article to Matrix Biology:The premier journal in the field of extracellular matrix biology with impact across many fields of biology and medicine.Published articles have a universal appeal, value, and utility to the research community worldwide.An international editorial board of key researchers in the field.Flexible publication: you can choose to publish open access.Your paper your way: no unnecessary formatting requests.No submission fees.No color page charges for online version.Matrix Biology Plus, a companion title to Matrix Biology, is an online-only, open access journal that welcomes papers reporting novel advances in the field of matrix biology and related research tools and resources without a strict requirement for novel biological mechanisms.Matrix Biology was established in 1980 as Collagen and Related Research, an international scientific journal for publication of research on the extracellular matrix. The journal became Matrix (1989-1993) and then Matrix Biology in 1994 to reflect the expansion of knowledge and interest in the diversity of extracellular matrix-associated molecules and their importance in development, health, and disease.
Molecular Immunology publishes original articles, reviews and commentaries on all areas of immunology, with a particular focus on description of cellular, biochemical or genetic mechanisms underlying immunological phenomena. Studies on all model organisms, from invertebrates to humans, are suitable. Examples include, but are not restricted to:Infection, autoimmunity, transplantation, immunodeficiencies, inflammation and tumor immunologyMechanisms of induction, regulation and termination of innate and adaptive immunityIntercellular communication, cooperation and regulationIntracellular mechanisms of immunity (endocytosis, protein trafficking, pathogen recognition, antigen presentation, etc)Mechanisms of action of the cells and molecules of the immune systemStructural analysisDevelopment of the immune systemComparative immunology and evolution of the immune system"Omics" studies and bioinformaticsVaccines, biotechnology and therapeutic manipulation of the immune system (therapeutic antibodies, cytokines, cellular therapies, etc)Technical developmentsArticles based primarily on studies in silico must adhere to the following principles; (i) The article must report novel analytical tools, approaches and/or databases rather than using publicly available ones; or (ii) The article must include substantial experimental validation of the conclusions obtained in silico.Manuscripts related to regulatory RNA (e.g. microRNAs, lncRNAs or circRNAs) are welcome but please note: (i) they must show clear physiological relevance supported by in vivo results or clinical observations; (ii) Correlations between regulatory RNA expression with human diseases should be experimentally validated; (iii) Functions associated with the regulatory RNAs must within the scope of the journal i.e. inflammation and/or immune responses.To be acceptable for publication, studies that describe correlations between disease and genetic polymorphisms would normally be required to include novel mechanistic findings underlying the associations.Clinical studies correlating disease and measurements of a molecule or cell type would likewise not be suitable for publication without novel mechanistic insights.Studies describing pharmacological agents are welcome if they provide significant novelty on the mechanisms of action.